妇科肿瘤实践中微创子宫切除术后当日出院:可行性、安全性、入院预测因素及不良结局
回顾性队列研究纳入2017年1月至2019年7月由妇科肿瘤医生完成的1124例微创子宫切除术患者,69.0%实现当日出院;30天不良结局罕见,当日出院者全报告并发症更少,但急诊就诊无差异。
要点
- 77.3%患者为癌症或癌前病变,69.0%成功当日出院。
- 术后入院预测因素包括高龄、手术时间长、操作并发症、下午2点后开始手术等。
- 当日出院者全报告并发症10.3% vs 入院者15.5%(p=.01),再入院2.8% vs 5.2%(p=.05)。
核心结论
- 在代表性妇科肿瘤实践中,微创子宫切除术后当日出院可行且安全;识别术后不良事件高风险患者有助于在缺乏标准化共识指南时指导当日出院选择,并确定康复预适应和加强围手术期支持的对象。
研究设计与样本
- 回顾性队列研究,纳入2017年1月至2019年7月于匹兹堡大学医学中心Magee妇女医院由妇科肿瘤医生完成的微创子宫切除术患者1124例。
主要发现
- 775例(69.0%)实现当日出院,77.3%患者有癌症或癌前病变。
- 30天不良结局罕见:并发症8.7%(国家手术质量改进计划)/11.9%(全报告),急诊就诊5.0%,再入院3.6%。
- 当日出院者全报告并发症10.3% vs 入院者15.5%(p=.01),急诊就诊4.6% vs 5.7%(p=.44),再入院2.8% vs 5.2%(p=.05)。
- 术后入院的预测因素包括高龄、距医院距离、手术时间长、操作并发症、下午2点后开始手术、根治性子宫切除、小切口开腹、粘连松解、心脏病、脑血管病、静脉血栓栓塞、糖尿病和神经系统疾病(p<.05)。
- 再入院预测因素仅行单变量分析,因事件数少未行多变量分析;手术时间长及心脏病和阻塞性肺疾病是复合不良事件变量的预测因素(p<.05)。
临床怎么用
- 作者认为,通过识别术后不良事件高风险患者,可在缺乏标准化机构或国家共识指南的情况下指导当日出院选择,并确定康复预适应和加强围手术期支持的对象。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVES: (1) Determine the feasibility and safety of same-day hospital discharge (SDHD) after minimally invasive hysterectomy (MIH) in a gynecologic oncology practice and (2) detail predictors of immediate postoperative hospital admission and multiple 30-day adverse outcomes. DESIGN: Retrospective cohort study. SETTING: University of Pittsburgh Medical Center Magee-Womens Hospital. PATIENTS: MIH by a gynecologic oncologist between January 2017 and July 2019. INTERVENTIONS: Clinicopathologic, operative, and medical characteristics, as well as 30-day postoperative complications, emergency department (ED) encounters, and hospital readmissions were extracted. Admitted and SDHD patients were compared using descriptive, chi-square, Fisher's exact, t test, and logistic regression analyses. Univariate and multivariable analyses (MVA) revealed predictors of postoperative hospital admission, 30-day readmission, and a 30-day composite adverse event variable (all-reported postoperative complications, ED encounter, and/or readmission). MEASUREMENTS AND MAIN RESULTS: A total of 1124 patients were identified, of which 77.3% had cancer or precancer; 775 patients (69.0%) underwent SDHD. On MVA, predictors of postoperative admission included older age, distance from hospital, longer procedure length, operative complications, start time after 2 PM, radical hysterectomy, minilaparotomy, adhesiolysis, cardiac disease, cerebrovascular disease, venous thromboembolism, diabetes, and neurologic disorders (p <.05). Moreover, 30-day adverse outcomes were rare (complication 8.7% National Surgical Quality Improvement Program/11.9% all-reported; ED encounter 5.0%; readmission 3.6%). SDHD patients had fewer all-reported complications (10.3% vs 15.5%, p = .01), no difference in ED encounters (4.6% vs 5.7%, p = .44), and fewer observed readmissions (2.8% vs 5.2%, p = .05). Predictors of readmission were identified on univariate; MVA was not feasible given the low number of events. Longer procedure length and cardiac and obstructive pulmonary disease were predictors of the composite adverse event variable (p <.05). CONCLUSION: SDHD is feasible and safe after MIH within a representative gynecologic oncology practice. Clinicopathologic, medical, and surgical predictors of multiple adverse outcomes were comprehensively described. By identifying patients at high risk of postoperative adverse events, we can direct SDHD selection in the absence of standardized institutional and/or national consensus guidelines and identify patients for prehabilitation and increased perioperative support.
引用
- Wield AM, Cohen MG, Toal CT, et al. Same-day Hospital Discharge after Minimally Invasive Hysterectomy in a Gynecologic Oncology Practice: Feasibility, Safety, Predictors of Admission, and Adverse Outcomes. J Minim Invasive Gynecol. 2022. PMID: 35595228. doi:10.1016/j.jmig.2022.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。